Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics.

Annick Ocmant,Sandrine Roisin,Régis De Meuter,Jonathan Brauner

Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics.

2021

Annick Ocmant
Sandrine Roisin
Régis De Meuter
Jonathan Brauner

In the wake of the COVID-19 pandemic, the antibody responses to SARS-CoV-2 virus have received a huge interest for diagnostic or epidemiological purposes. This article is protected by copyright. All rights reserved.

Keywords:

Antibody
Coronavirus disease 2019
clinical performance
Virus
ADVIA Centaur
severe acute respiratory syndrome coronavirus 2
Virology
antibody response
chemiluminescent immunoassay
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations